|
NDUFB7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.887000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.309600E-01 |
| Normal-vs-Stage2 |
3.527400E-01 |
| Normal-vs-Stage3 |
5.558800E-01 |
| Normal-vs-Stage4 |
8.840600E-01 |
| Stage1-vs-Stage2 |
4.414300E-02 |
| Stage1-vs-Stage3 |
4.683800E-02 |
| Stage1-vs-Stage4 |
6.766400E-01 |
| Stage2-vs-Stage3 |
6.281200E-01 |
| Stage2-vs-Stage4 |
4.774800E-01 |
| Stage3-vs-Stage4 |
6.919400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.259800E-01 |
| Normal-vs-AfricanAmerican |
4.029000E-01 |
| Normal-vs-Asian |
7.005400E-01 |
| Caucasian-vs-AfricanAmerican |
4.867200E-01 |
| Caucasian-vs-Asian |
8.483200E-01 |
| AfricanAmerican-vs-Asian |
9.193200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.454400E-01 |
| Normal-vs-Female |
5.582600E-01 |
| Male-vs-Female |
6.211400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.235200E-01 |
| Normal-vs-Extreme_Weight |
1.690010E-01 |
| Normal-vs-Obese |
7.857200E-01 |
| Normal-vs-Extreme_Obese |
1.955570E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.937200E-01 |
| Normal_Weight-vs-Obese |
4.258600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.990600E-01 |
| Extreme_Weight-vs-Obese |
1.402350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.490600E-01 |
| Obese-vs-Extreme_Obese |
2.973400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.728800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.042800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.170200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.129200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.869200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.491200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.416000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.384830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.545600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.050150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.729380E-01 |
| Normal-VS-Type2 PRCC |
7.884800E-01 |
| Normal-VS-KIRP CIMP |
3.402600E-03 |
| Normal-VS-Unclassified PRCC |
6.377000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.056190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.43580000000221E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.341200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.863530E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.318600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.763100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.766600E-01 |
| Normal-vs-N1 |
2.161800E-02 |
| Normal-vs-N2 |
5.440600E-01 |
| N0-vs-N1 |
1.699030E-03 |
| N0-vs-N2 |
3.447800E-01 |
| N1-vs-N2 |
5.448600E-01 |
|
|
